MVIS
Microvision Inc
1.60$
-3.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.6% | -4.2% | -16.7% | -14.7% | +37.3% | -3.6% | +20.5% | +7.3% | -31.6% | +6.9% | -19.6% | |
| – | -5.1% | -5.1% | -19.1% | -20.3% | +55.5% | -4.2% | +30.6% | +11.4% | -29.5% | -33.2% | -36.8% | |
| – | -8.5% | -1.9% | -39.5% | -38.4% | +229.8% | -4.7% | +42.7% | -1.7% | -55.6% | +42.5% | -41.0% | |
| – | -5.5% | -1.0% | -22.3% | -23.9% | +72.9% | -7.6% | +32.4% | +8.9% | -24.8% | -38.4% | -41.0% | |
| – | +28.2% | +18.1% | +75.7% | -88.2% | +299.1% | -72.8% | -58.7% | -61.5% | +17.5% | +1,457.4% | +25.0% | |
| – | +7.1% | -3.5% | +12.4% | +6.7% | -48.9% | +10.5% | +141.8% | +32.7% | -90.8% | +440.7% | -9.1% | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | |
| – | -3.0% | -3.3% | -21.5% | -4.0% | -12.7% | -2.1% | -2.1% | -2.2% | -99.7% | +42,593.8% | +0.2% | |
| – | -10.2% | -10.2% | -18.7% | -9.3% | +223.1% | -12.2% | 0.0% | -5.4% | -20.9% | +48.5% | -3.8% | |
| – | -14.8% | -13.4% | -28.7% | -16.1% | +333.1% | -8.9% | +2.3% | -6.8% | -24.4% | +71.7% | -2.6% | |
| – | -4.6% | -6.7% | -2.5% | +1.7% | +1,153.1% | +22.9% | +8.0% | -10.1% | -29.3% | +63.6% | -20.1% | |
| – | -1.0% | -4.8% | -33.0% | +2.7% | -23.9% | +12.0% | +23.3% | -14.4% | +21.6% | +178.7% | +29.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.5% | -2.1% | -16.1% | -16.3% | -25.9% | +9.1% | +44.9% | +17.7% | -38.8% | -28.8% | -47.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.2% | +3.2% | +6.1% | +2.1% | +3.0% | +7.5% | +7.9% | +16.0% | +3.4% | +1.0% | +8.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.